Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 5683Erstellt: 23. Oktober 2026

Hydrochloric Acid → Hexanoic acid, 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-oxo-, 1,1-dimethylethyl ester, (R)-(9CI)

https://huagongshe.com/de/reaction/5683

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktHydrochloric AcidHCID 313—
Edukt1,1'-CarbonyldiimidazoleHCID 68263—
EduktDiisopropylethylamineHCID 81531—
Edukt2-Tert-butylpropanedioic acidHCID 242752—
EduktMagnesium ChlorideHCID 5360315—
EduktPotassiumHCID 5462222—
Edukt(R)-3-((tert-Butyldimethylsilyl)oxy)-4-cyanobutanoic acidHCID 13732513—
EduktL-Ascorbic AcidHCID 54670067—
EduktErythorbic AcidHCID 54675810—
LösungsmittelAcetonitrileHCID 6342—
LösungsmittelTetrahydrofuranHCID 8028—
LösungsmittelEthyl AcetateHCID 8857—
ProduktHexanoic acid, 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-oxo-, 1,1-dimethylethyl ester, (R)-(9CI)HCID 15045171—

Reaktionsbedingungen

Temperatur25 °C

Reaktionsschritte

Thus, the optically active compounds are prepared from the known isoascorbic acid using the methodology described by Volante R. P. et al., in U.S. Pat. No. 4,611,067 but in that case starting with ascorbic acid. This establishes the optically active centers desired in Formula XXVa and Formula XXIIIa as R. Thus, the (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid of Formula XXIX is treated with carbonyldiimidazole in tetrahydrofuran at 0° C. to -40° C., preferably -20° C., warmed to 25° C. and the activated acid derivative is not isolated but the solution is added to a suspension of a salt of 1,1-dimethylethyl malonic acid such as, for example, the potassium salt of 1,1-dimethylethyl malonic acid (half ester, half salt) anhydrous magnesium chloride, and an amine such as, for example, diisopropylethylamine in acetonitrile at -10° C. to 20° C. preferably at 5° C. The mixture is poured into a mixture of 1N hydrochloric acid and ethyl acetate to afford the (R)-1,1-dimethylethyl 6-cyano-5-[(1,1-dimethylethyl)dimethylsilyl]oxy-3-oxohexanoate of Formula XXVIII. The ketone of Formula XXVIII is treated with fluoride ion at 0° C. to 65° C., preferably 25° C. to afford the (R)-1,1-dimethylethyl 6-cyano-5-hydroxy-3-oxo-hexanoate of Formula XXVII. The ketone of Formula XXVII is treated with triethylborane and air (or methoxydiethylborane without air) followed by sodium borohydride and methanol in tetrahydrofruan at -78° C. to -110° C., preferably -100° C. to afford [R-(R*,R*)]-1,1-dimethylethyl 6-cyano-3,5-hydroxyhexanoate of Formula XXVI. The diol of Formula XXVI is treated with a ketal forming reagent as such as, for example, acetone, dimethoxypropane, 2-methoxypropene, benzaldehyde, cyclopentanone, cyclohexanone, 1,1-dimethoxycyclopentane, 1,1-dimethoxycyclohexane and the like, in the presence of an acid such as, for example, camphorsulfonic acid, para-toluenesulfonic acid, and the like, in the presence of excess reagent or in an inert solvent such as, for example, dichloromethane, and the like, at 0° C. to the reflux temperature of the reagent or solvent to afford a compound of Formula XXVa wherein R7 and R8 are independently hydrogen, alkyl of from one to three carbon atoms, phenyl or R7 and R8 are taken together as --(CH2)n --, wherein n is 4 or 5.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS05245047
Quelldatensatzuspto-grants-1993_09
ORD IDord-28eff96ac1a74bc0827f6036314dc85e
Quellennotizuspto-grants-1993_09